We read with interest the review by Prieser et al. on the perioperative management of oral glucose-lowering agents in patients with type 2 diabetes mellitus.1 The authors recommend (table 1) that sodium glucose cotransporter–2 inhibitors be ceased 24 h before elective interventions.1 No allowance is made for the severity of the procedure (minor vs. major surgery) or type of procedure. However, the authors do acknowledge that other sources recommend a longer duration of withholding these medications before elective procedures. Ceasing them just on the day of the procedure may be suitable for minor interventions where early oral intake is possible. For procedures where return to preoperative state is expected to be delayed, some governing bodies recommend withholding these agents more than 24 h. The Australian Diabetes Society (Melbourne, Australia) recommends withholding 2 days before...
Skip Nav Destination
Close
Article navigation
February 2021
Correspondence|
February 2021
Perioperative Management of Glucose-lowering Drugs: Comment
Venkatesan Thiruvenkatarajan, M.D., D.N.B., F.A.N.Z.C.A.;
Venkatesan Thiruvenkatarajan, M.D., D.N.B., F.A.N.Z.C.A.
Search for other works by this author on:
David Jesudason, F.R.A.C.P., Ph.D.;
David Jesudason, F.R.A.C.P., Ph.D.
Search for other works by this author on:
Nagesh Nanjappa, M.D., D.N.B., F.A.N.Z.C.A.;
Nagesh Nanjappa, M.D., D.N.B., F.A.N.Z.C.A.
Search for other works by this author on:
Emily Jane Meyer, M.B.B.S., F.R.A.C.P.;
Emily Jane Meyer, M.B.B.S., F.R.A.C.P.
Search for other works by this author on:
Roelof M. Van Wijk, Ph.D., F.A.N.Z.C.A.
Roelof M. Van Wijk, Ph.D., F.A.N.Z.C.A.
Search for other works by this author on:
(Accepted for publication October 29, 2020. Published online first on December 2, 2020.)
The Queen Elizabeth Hospital, Woodville, Australia (V.T.). Venkatesan.Thiruvenkatarajan@sa.gov.au
Anesthesiology February 2021, Vol. 134, 349–350.
Connected Content
Citation
Venkatesan Thiruvenkatarajan, David Jesudason, Nagesh Nanjappa, Emily Jane Meyer, Roelof M. Van Wijk; Perioperative Management of Glucose-lowering Drugs: Comment. Anesthesiology 2021; 134:349–350 doi: https://doi.org/10.1097/ALN.0000000000003626
Download citation file:
Close
Sign in
ASA members enjoy complimentary access to ASA publications, as well as a variety of educational resources. Join today!
ASA Members and Registered Users
Sign InInstitutional Administrators
Admin PortalPay-Per-View Access
$35.00
155
Views
0
Citations
Citing articles via
Most Viewed
Related Articles
Significance of Postoperative Glycosuria and Ketonuria in Nondiabetic Adults
Anesthesiology (January 1953)
Perioperative Management of Glucose-lowering Drugs: Comment
Anesthesiology (February 2021)
Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes
Anesthesiology (August 2020)
Changes in Plasma Creatinine Concentration after Cardiac Anesthesia with Isoflurane, Propofol, or Sevoflurane: A Randomized Clinical Trial
Anesthesiology (October 2001)
Role of Renal Cysteine Conjugate β-Lyase in the Mechanism of Compound A Nephrotoxicity in Rats
Anesthesiology (January 1997)